OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Virology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Transmission patterns of hepatitis E virus	177
Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines	139
Editorial overview: The virome in health and disease (2022)	106
Editorial Board	79
Editorial Board	79
Editorial Board	76
Editorial Board	71
Editorial Board	63
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	62
Editorial Board	62
Editorial overview: Engineering elimination of chronic viral hepatitis	61
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	61
Inhaled aerosol viral-vectored vaccines against tuberculosis	60
Cryo-electron microscopy of nodavirus RNA replication organelles illuminates positive-strand RNA virus genome replication	59
Seeing and touching adenovirus: complementary approaches for understanding assembly and disassembly of a complex virion	58
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	55
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	52
Alohomora! What the entry mechanisms tell us about the evolution and diversification of giant viruses and their hosts	51
The morphogenesis of different giant viruses as additional evidence for a common origin of Nucleocytoviricota	45
Editorial overview: Special issue on antiviral strategies in Current Opinion in Virology	44
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	43
Gradual adaptation of animal influenza A viruses to human-type sialic acid receptors	42
Unresolved questions in the zoonotic transmission of MERS	42
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	42
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	41

Host cell-intrinsic innate immune recognition of SARS-CoV-2	38
Structural insights into hepatitis C virus neutralization	37
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	36
Role of trained innate immunity against mucosal cancer	36
Retasking of canonical antiviral factors into proviral effectors	35
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success	34
Tissue-resident memory T cells in protective immunity to influenza virus	34
When good turns bad: how viruses exploit innate immunity factors	33
Asymmetry in icosahedral viruses	33
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	33